Suppr超能文献

血清中热休克蛋白抗体对人类肾移植排斥反应没有诊断价值。

Serum antibodies to heat shock proteins are of no diagnostic value for human kidney allograft rejection.

作者信息

Trieb K, Gerth R, Berger P, Margreiter R

机构信息

Department for Transplant Surgery, University Hospital Innsbruck, Austria.

出版信息

Transpl Int. 2000;13(1):46-8. doi: 10.1007/s001470050007.

Abstract

Because of the prevailing evidence that heat shock proteins (hsp) are involved in transplantation immunology, we investigate in this study the serum levels of anti-hsp60, and anti-hsp70 antibodies in human kidney allograft recipients. We analyzed 67 sera from 20 patients immediately before and 2 weeks after receiving a kidney allograft, and from 27 healthy age-matched controls with an ELISA. Eleven kidneys had normal allograft function, six had a mild rejection episode, all of which could be reversed successfully; three kidneys had to be removed later on because of resistant rejection. Hsp antibody frequency and titres were the same for transplant recipients and for healthy controls. In patients receiving a kidney allograft, no difference in the level of hsp-antibodies before and after transplantation was observed. Additionally, anti-hsp60 and anti-hsp70 antibody titres were found to be independent of the clinical course. These data suggest that the determination of anti-hsp60 and 70 antibody titers are of no diagnostic value for renal allograft rejection.

摘要

鉴于目前有证据表明热休克蛋白(hsp)参与移植免疫学,我们在本研究中调查了人类肾移植受者血清中抗hsp60和抗hsp70抗体的水平。我们用酶联免疫吸附测定法(ELISA)分析了20例接受肾移植患者在接受移植前即刻和移植后2周的67份血清,以及27名年龄匹配的健康对照者的血清。11个移植肾具有正常的移植肾功能,6个发生了轻度排斥反应,所有这些排斥反应均成功逆转;3个移植肾后来因难治性排斥反应而不得不被切除。移植受者和健康对照者的hsp抗体频率和滴度相同。在接受肾移植的患者中,未观察到移植前后hsp抗体水平的差异。此外,发现抗hsp60和抗hsp70抗体滴度与临床病程无关。这些数据表明,抗hsp60和70抗体滴度的测定对肾移植排斥反应没有诊断价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验